Florida Surgeon General Cites Debunked Claims In Calling For Halt Of COVID Shots
Federal health officials, as well as other medical experts, have dismissed Dr. Joseph Ladapo’s concerns as factually inaccurate and dangerous to human health.
Similar Posts
Covid inquiry: Quarantining people sooner ‘might have avoided’ first lockdown, says Hunt
The UK should have prepared to test and isolate more, the ex-health secretary tells the Covid inquiry.
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…
So THAT’S Why Drinking Alcohol Makes You Feel Worse As You Get Older
“Drink in moderation” is advice we hear often, but as most people can attest to after a booze-filled holiday season, it isn’t easy to stick to. When we can stick to moderate drinking, however, we usually feel pretty good about ourselves. According to the 2020-2025 Dietary Guidelines for Americans, moderate drinking is defined as no…
Assisted deaths may soon be a reality for those suffering from mental illness in Canada
This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Under a new law that would go into effect in March, patients suffering from mental illness in Canada would be able to have access to an assisted death, according to…
Can Denmark’s world-beating drugs maker stay ahead?
Thanks to its weight loss drug, Novo Nordisk briefly became Europe’s most valuable firm in 2023.
MoonLake Immunotherapeutics explores sale | Reuters News Agency
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
